Cannex Capital Holdings Inc Stock Canadian Securities Exchange
Equities
CA13768L1085
Pharmaceuticals
Sales 2024 * | 120M 165M | Sales 2025 * | - | Capitalization | 92.72M 128M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 0.77 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 0% |
Latest transcript on Cannex Capital Holdings Inc
Managers | Title | Age | Since |
---|---|---|---|
Founder | 38 | - | |
Andrew Thut
CEO | Chief Executive Officer | 50 | 14-09-30 |
Peter Kampian
DFI | Director of Finance/CFO | 65 | Nov. 30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Rob Hunt
CHM | Chairman | 51 | 22-04-11 |
Anthony Dutton
PRN | Corporate Officer/Principal | 66 | - |
Chetan Gulati
BRD | Director/Board Member | 46 | 20-11-30 |
1st Jan change | Capi. | |
---|---|---|
+37.12% | 6.02B | |
-14.61% | 4.55B | |
-10.58% | 3.13B | |
+0.86% | 3.07B | |
-0.94% | 2.57B | |
+36.18% | 1.82B | |
-10.82% | 1.63B | |
-4.89% | 1.57B | |
-12.50% | 1.54B |